Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Feng Zhang and David Liu's base-editing CRISPR startup officially launches with $87M

fiercebiotechMay 16, 2018

Tag: CRISPR , Feng Zhang , David Liu's

PharmaSources Customer Service